28389629|t|Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1 -mediated AMPK and JNK activation
28389629|a|mTOR activation suppresses autophagy by phosphorylating ULK1 at S757 and suppressing its enzymatic activity. Here we report that feedback activation of mTOR in the PI-3 kinase pathway by two p70 S6 kinase (S6K1) inhibitors (PF-4708671 and A77 1726, the active metabolite of an immunosuppressive drug leflunomide) or by S6K1 knockdown did not suppress but rather induced autophagy. Suppression of S6K1 activity led to the phosphorylation and activation of AMPK, which then phosphorylated ULK1 at S555. While mTOR feedback activation led to increased phosphorylation of ULK1 at S757, this modification did not the disrupt ULK1 - AMPK interaction nor dampen ULK1 S555 phosphorylation and the induction of autophagy. In addition, inhibition of S6K1 activity led to JNK activation, which also contributed to autophagy. 5Z-7-oxozeaenol, a specific inhibitor of TAK1, or TAK1 siRNA blocked A77 1726 -induced activation of AMPK and JNK, and LC3 lipidation. Taken together, our study establishes S6K1 as a key player in the PI-3 kinase pathway to suppress autophagy through inhibiting AMPK and JNK in a TAK1 -dependent manner.
28389629	0	10	Inhibition	T040	C2248397
28389629	14	27	p70 S6 kinase	T116,T126	C2827383
28389629	29	33	S6K1	T116,T126	C2827383
28389629	35	43	activity	T044	C0243102
28389629	47	55	A77 1726	T109,T121	C0100724
28389629	61	78	active metabolite	T123	C0870883
28389629	82	93	leflunomide	T109,T121	C0063041
28389629	103	112	autophagy	T043	C0004391
28389629	121	125	TAK1	T116,T126	C0379816
28389629	136	140	AMPK	T116,T126	C2350345
28389629	145	148	JNK	T116,T126	C0291988
28389629	149	159	activation	T045	C0599177
28389629	160	164	mTOR	T116,T126	C1307407
28389629	165	175	activation	T045	C0599177
28389629	176	186	suppresses	T169	C1260953
28389629	187	196	autophagy	T043	C0004391
28389629	200	215	phosphorylating	T044	C1158886
28389629	216	220	ULK1	T116,T126	C1313678
28389629	233	244	suppressing	T169	C1260953
28389629	249	267	enzymatic activity	T044	C2267219
28389629	298	308	activation	T045	C0599177
28389629	312	316	mTOR	T116,T126	C1307407
28389629	324	335	PI-3 kinase	T116,T126	C0044602
28389629	336	343	pathway	T044	C0037080
28389629	351	364	p70 S6 kinase	T116,T126	C2827383
28389629	366	370	S6K1	T116,T126	C2827383
28389629	372	382	inhibitors	T121	C0014432
28389629	384	394	PF-4708671	T109,T121	C2976138
28389629	399	407	A77 1726	T109,T121	C0100724
28389629	413	430	active metabolite	T123	C0870883
28389629	437	459	immunosuppressive drug	T121,T129	C0021081
28389629	460	471	leflunomide	T109,T121	C0063041
28389629	479	483	S6K1	T028	C1419748
28389629	484	493	knockdown	T063	C2350567
28389629	502	510	suppress	T169	C1260953
28389629	530	539	autophagy	T043	C0004391
28389629	541	552	Suppression	T169	C1260953
28389629	556	560	S6K1	T116,T126	C2827383
28389629	561	569	activity	T044	C1537044
28389629	581	596	phosphorylation	T044	C1158886
28389629	601	611	activation	T045	C0599177
28389629	615	619	AMPK	T116,T126	C2350345
28389629	632	646	phosphorylated	T044	C1158886
28389629	647	651	ULK1	T116,T126	C1313678
28389629	667	671	mTOR	T116,T126	C1307407
28389629	681	691	activation	T045	C0599177
28389629	709	724	phosphorylation	T044	C1158886
28389629	728	732	ULK1	T116,T126	C1313678
28389629	780	784	ULK1	T116,T126	C1313678
28389629	787	791	AMPK	T116,T126	C2350345
28389629	792	803	interaction	T044	C0872079
28389629	815	819	ULK1	T116,T126	C1313678
28389629	825	840	phosphorylation	T044	C1158886
28389629	849	858	induction	T169	C0205263
28389629	862	871	autophagy	T043	C0004391
28389629	886	896	inhibition	T040	C2248397
28389629	900	904	S6K1	T116,T126	C2827383
28389629	905	913	activity	T044	C0243102
28389629	921	924	JNK	T116,T126	C0291988
28389629	925	935	activation	T045	C0599177
28389629	963	972	autophagy	T043	C0004391
28389629	974	989	5Z-7-oxozeaenol	T121	C1254351
28389629	1002	1011	inhibitor	T121	C0014432
28389629	1015	1019	TAK1	T116,T126	C0379816
28389629	1024	1028	TAK1	T116,T126	C0379816
28389629	1029	1034	siRNA	T114,T123	C1099354
28389629	1043	1051	A77 1726	T109,T121	C0100724
28389629	1061	1071	activation	T045	C0599177
28389629	1075	1079	AMPK	T116,T126	C2350345
28389629	1084	1087	JNK	T116,T126	C0291988
28389629	1093	1096	LC3	T116	C3540600
28389629	1097	1107	lipidation	T044	C1157479
28389629	1147	1151	S6K1	T116,T126	C2827383
28389629	1175	1186	PI-3 kinase	T116,T126	C0044602
28389629	1187	1194	pathway	T044	C0037080
28389629	1198	1206	suppress	T169	C1260953
28389629	1207	1216	autophagy	T043	C0004391
28389629	1225	1235	inhibiting	T052	C3463820
28389629	1236	1240	AMPK	T116,T126	C2350345
28389629	1245	1248	JNK	T116,T126	C0291988
28389629	1254	1258	TAK1	T116,T126	C0379816